VA
PHVS icon

VR Adviser’s Pharvaris PHVS Stock Holding History

VR Adviser’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-674,599
Closed -$16.8M – 31
2025
Q3 		$16.8M Sell
674,599
-1,373,021
-67% -$30.5M 0.95% 25
2025
Q2 		$36M Sell
2,047,620
-1,065,100
-34% -$17.2M 2.7% 10
2025
Q1 		$48.9M Sell
3,112,720
-107,410
-3% -$1.81M 4.16% 7
2024
Q4 		$61.7M Sell
3,220,130
-175,476
-5% -$3.61M 4.24% 8
2024
Q3 		$62.9M Hold
3,395,606
– – 3.29% 10
2024
Q2 		$63.8M Hold
3,395,606
– – 4.07% 8
2024
Q1 		$78.5M Hold
3,395,606
– – 3.73% 6
2023
Q4 		$95.2M Buy
3,395,606
+1,832,093
+117% +$37.1M 6.53% 3
2023
Q3 		$32.6M Buy
1,563,513
+237,313
+18% +$4.37M 3.44% 9
2023
Q2 		$20.1M Buy
+1,326,200
New +$12.8M 3.21% 14
2021
Q4 		– Sell
-552,882
Closed -$9.8M – 29
2021
Q3 		$9.8M Sell
552,882
-350,000
-39% -$5.99M 1.26% 20
2021
Q2 		$16.8M Hold
902,882
– – 2.04% 18
2021
Q1 		$25.3M Buy
+902,882
New +$28.4M 2.75% 14

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

VR Adviser's PHVS Position: Q4 2025 in Review

VR Adviser sold out of Pharvaris (PHVS) in Q4 2025, closing a stake of 674,599 shares — an estimated $16.8M sold.

VR Adviser first reported a position in PHVS in Q1 2021 and held it in 13 quarters. The position peaked at $95.2M in Q4 2023. 106 funds tracked by Wall St. Rank hold PHVS as of Q4 2025.

  • VR Adviser reported no remaining Pharvaris position as of Q4 2025 after selling out during the quarter.
  • VR Adviser sold 674,599 Pharvaris shares in Q4 2025, an estimated $16.8M.
  • VR Adviser first reported a position in Pharvaris in Q1 2021 and held it in 13 quarters.
  • VR Adviser's Pharvaris position peaked at $95.2M in Q4 2023.
  • 106 funds tracked by Wall St. Rank held Pharvaris as of Q4 2025.

Based on VR Adviser's 13F filing for Q4 2025, filed 17 Feb 2026.